ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 195,97
0,35%
Dow Jones
39 806,77
-0,49%
DAX
18 768,96
0,33%
Brent Oil
83,085
-0,53%
Bitcoin
70 957,45
-0,69%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Centurion Res (CEN)

  7. Centurion Res (CEN) Actualités

CEN

Centurion Res (CEN)

Centurion Res
De:
Trier par:
 Showing the most relevant articles for your search:LSE:CEN
DateHeureSourceTitreSymboleSociété
07/09/200715h15PR Newswire (US)Pershing Square Sends Letter Updating Ceridian StockholdersEU:CEN
11/12/200400h43PR Newswire (US)Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value IndicesEU:CEN
27/01/200413h23UK RegulatoryHolding(s) in CompanyEU:CENCenes Pharmaceutical
20/01/200417h04UK RegulatoryAdditional ListingEU:CENCenes Pharmaceutical
16/01/200414h44UK RegulatoryNotice of EGMEU:CENCenes Pharmaceutical
12/01/200417h24UK RegulatoryCENES PHARMACEUTICALS PLC (''the Company'') - HOLDING IN COMPANYEU:CENCenes Pharmaceutical
12/01/200408h01UK RegulatoryCeNeS appoints Piper Jaffray Ltd. and Nomura International plcEU:CENCenes Pharmaceutical
08/01/200408h00UK RegulatoryDirectorate ChangeEU:CENCenes Pharmaceutical
23/12/200313h14UK RegulatoryDirector ShareholdingEU:CENCenes Pharmaceutical
24/11/200308h01UK RegulatoryAcquisitionEU:CENCenes Pharmaceutical
13/10/200309h00UK RegulatoryResearch UpdateEU:CENCenes Pharmaceutical
30/09/200309h34UK RegulatoryCeNeS Reports 2003 Interim ResultsEU:CENCenes Pharmaceutical
26/09/200313h57UK RegulatoryNotice of ResultsEU:CENCenes Pharmaceutical
12/09/200310h00UK RegulatoryBoard ChangeEU:CENCenes Pharmaceutical
01/09/200309h03UK RegulatoryResearch Update and conference addressesEU:CENCenes Pharmaceutical
12/08/200313h27UK RegulatoryIssue of EquityEU:CENCenes Pharmaceutical
12/08/200309h01UK RegulatoryAGM StatementEU:CENCenes Pharmaceutical
15/07/200311h43UK RegulatoryNotice of AGMEU:CENCenes Pharmaceutical
14/07/200316h45UK RegulatoryBlocklisting Interim ReviewEU:CENCenes Pharmaceutical
11/07/200318h06UK RegulatoryAIM Prospective AdmissionEU:CENCenes Pharmaceutical
10/07/200317h33UK RegulatoryTransfer to AIMEU:CENCenes Pharmaceutical
02/07/200309h01UK RegulatoryMiscellaneous: Transfer to AIMEU:CENCenes Pharmaceutical
02/07/200309h01UK RegulatoryDirectorate changeEU:CENCenes Pharmaceutical
18/06/200309h00UK RegulatoryRe Joint VentureEU:CENCenes Pharmaceutical
30/05/200316h36UK RegulatoryResult of EGMEU:CENCenes Pharmaceutical
22/05/200309h01UK RegulatoryDisposalEU:CENCenes Pharmaceutical
16/04/200311h32UK RegulatoryPreliminary ResultsEU:CENCenes Pharmaceutical
16/04/200310h02UK RegulatoryStatement re CeNeS Announces Sale of Pharmaceutical Products raising a total of over £9m in cashEU:CENCenes Pharmaceutical
25/07/200217h20UK RegulatoryEMM DisclosureEU:CENCeNeS Pharmaceutical
 Showing the most relevant articles for your search:LSE:CEN

Dernières Valeurs Consultées

LBNK
WEYUUSDT
WEYU
LSE
MLD
Mirland
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés